We use a session cookie and first-party analytics to run this site — no third-party trackers, no ads. Details in our Privacy Policy.
RESEARCH From the Research Desk — The sub-Rs 100 crore acquisition market, sized. Read it →
Home/ Cases/ JRN PHARMA AND LABORATORIES LLP
● UNDER CIRP

JRN PHARMA AND LABORATORIES LLP

Corporate insolvency resolution — proceedings ongoing · source: Live - Newly Admitted

Pharmaceutical manufacturing project at Borgaon, Morigaon, Assam; debtor alleged machinery remained uninstalled.

Bench NCLT Guwahati CIN AAR0055 Admitted 08 Jul 2026 Initiated by Anchor Mark Private Limited Last process activity 28 Jul 2026 · claims re-verified · active
OWED MONEY BY THIS COMPANY?
The date in the public announcement passed on 22 Jul 2026, but the window has not shut. Regulation 12 lets a creditor file up to 6 Oct 2026 — 15 days left — ninety days from admission on 8 Jul 2026, or later still if the request for resolution plans has not yet gone out. File with Purshotam Gaggar now.
Reg. 12, IBBI (CIRP) Regulations 2016
How to file your claim → The professional’s record →

Case record

the public record -- figures open below

Corporate insolvency record of JRN PHARMA AND LABORATORIES LLP, commenced 08 Jul 2026, at NCLT Guwahati, initiated by Anchor Mark Private Limited. Current status: Under CIRP.

CIN
AAR0055
NCLT Bench
Guwahati
Initiated by
Anchor Mark Private Limited
Public Announcement
11 Jul 2026
Commencement
08 Jul 2026
Resolution Professional
Purshotam Gaggar →
Subscriber access

Full case intelligence is gated

This page's financial detail is available to stressed.in subscribers — for ARCs, PE funds and resolution professionals.

Admitted claims Recovery waterfall & haircut Sector benchmarks Case timeline & professionals Committee of creditors Plan value & CoC vote Intelligence note
See plans →
Just this company — Rs 1,999 · apply for access →

One company, bought outright — yours permanently, including future updates. Subscribe within 30 days and the whole Rs 1,999 comes off your first month, so starting with one case costs nothing against subscribing later.

Questions? WhatsApp us →
Sources, basis and disclaimers → ·
report an error